HUL in focus after commencing commercial production at Assam unit

Hindustan Unilever (HUL) announced that it has commenced the commercial production in its new manufacturing unit at Assam on 15 March 2017. The announcement was made after market hours yesterday, 21 March 2017. The company had earlier informed about setting up new manufacturing unit in Assam to augment the production capacity of personal care products of the company.

Indiabulls Housing Finance announced that it has allotted its seventh tranche of secured, redeemable, non-convertible debentures of face value Rs 10 lakh each (NCDs) aggregating Rs 600 crore i.e. Rs 500 crore plus Greenshoe option of Rs 100 crore. The announcement was made after market hours yesterday, 21 March 2017.

Mawana Sugars announced that the board of directors of the company, vide resolution dated 21 March 2017, has agreed to enter into one time settlement (OTS) with Punjab National Bank (PNB) Muzaffarnagar, Uttar Pradesh. The purpose of the OTS was for resolution of non performing asset (NPA) debt. The company settled total memoranda dues of Rs 109.46 crores (as per PNB), for a consolidated agreed amount of Rs 79.79 crore, payable over 15 month without interest. The announcement was made after market hours yesterday, 21 March 2017.

ABC Bearings announced that it has sold its entire 2.5% equity stake in NSK-ABC Bearings Private Ltd (NABI) to NSK India Sales Company Pvt. Ltd, pursuant to the terms of a share purchase agreement dated 21st March 2017 entered into between ABC, NABI, NSK and the purchaser. The announcement was made after market hours yesterday, 21 March 2017.

Dena Bank announced that the board of directors of the bank approved raising of share capital of the bank upto an amount of Rs 800 crore. The capital will be raised by issue of shares to Government of India upto an amount of Rs 600 crore, by issue of shares to LIC of India upto an amount of Rs 180 crore and to GIC of India upto an amount of Rs 20 crore on preferential issue basis. The announcement was made after market hours yesterday, 21 March 2017.

Wockhardt announced that abbreviated new drug application (ANDA) of Piperacillin and Tazobactam for Injection USP, 40.5 g/vial, pharmacy bulk package submitted by Wockhardt Bio AG, subsidiary of the company has been approved by US Food and Drug Administration (USFDA). Wockhardt's ANDA was determined to be therapeutically equivalent to the reference listed drug (RLD) Zosyn for Injection 40.5g/vial, pharmacy bulk package of Wyeth Pharmaceuticals Inc.

Wockhardt Bio AG had filed this ANDA in collaboration with Fresinius Kabi, Italy (FKAI), where the product development was completed. The ANDA will be manufactured commercially at FKAI, Mitim, Italy. The announcement was made after market hours yesterday, 21 March 2017.

Powered by Capital Market - Live News